# Alkermes, Inc. (NASDAQ: ALKS), Waltham, MA – FDA Inspections

Source: https://www.keypedia.com/companies/alkermes-inc/2a5efa83-7984-4306-9df7-b25ba2decb67

> Inspection records and compliance data for Alkermes, Inc. in Waltham, Massachusetts. 4 FDA inspections on record, 1 warning letter, last inspected May 28, 2015. Publicly traded as NASDAQ: ALKS.

---

## Details

- Name: Alkermes, Inc.
- FEI Number: 1000513229
- Address Line 1: 852 Winter St
- City: Waltham
- State: Massachusetts
- Zip Code: 02451
- Country Name: United States
- Address: 852 Winter St, Waltham, Massachusetts 02451, United States
- Country: United States

## Stock

- Stock ticker: ALKS
- Exchange: NASDAQ
- Share price: $46.98
- Market cap: $7.9B
- Price as of: November 13, 2026

## Related Documents

- [CRL - Alkermes, Inc. - Unknown Date](https://www.keypedia.com/records/crl/alkermes-inc/9d497685-0f99-4431-bfa5-7f1b7d0ff700) — source: FDA, date: Invalid Date
- [WARNING_LETTER - Alkermes, Inc. - 2019-12-02](https://www.keypedia.com/records/warning_letter/alkermes-inc/79265bc2-9d7b-4314-8900-942b41085cfe) — source: FDA, date: December 2, 2019
- FDA Inspection 933726 - Alkermes, Inc. - 2015-05-28 — classification: No Action Indicated (NAI), source: FDA, date: May 28, 2015
- FDA Inspection 859795 - Alkermes, Inc. - 2013-12-12 — classification: No Action Indicated (NAI), source: FDA, date: December 12, 2013
- FDA Inspection 790639 - Alkermes, Inc. - 2012-06-15 — classification: No Action Indicated (NAI), source: FDA, date: June 15, 2012
- [FDA Inspection 615049 - Alkermes, Inc. - 2009-09-29](https://www.keypedia.com/records/fda_inspections/alkermes-inc/a56842a6-c87e-407e-bc6c-c7f4058c4796) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 29, 2009

## Related Companies

- [Boston University National Emerging Infectious Disease Laboratories](https://www.keypedia.com/companies/boston-university-national-emerging-infectious-disease-laboratories/050558e2-09bc-4c20-856b-d9bbdf2a9300)
- [Ora, Inc.](https://www.keypedia.com/companies/ora-inc/d11882cf-8c73-4ece-8820-7dff1d2cb932)
- [Sage Therapeutics, Inc.](https://www.keypedia.com/companies/sage-therapeutics-inc/a4cede95-98e8-4915-9d60-d91f89366850)
- [Dana-Farber Harvard Cancer Center](https://www.keypedia.com/companies/dana-farber-harvard-cancer-center/cad8f71c-43e5-4925-bc6a-1b36f2b246da)
- [Disc Medicine, Inc.](https://www.keypedia.com/companies/disc-medicine-inc/41c1b387-b1c3-421b-bb79-4bc10d137edf)
- [Agios Pharmaceuticals, INC.](https://www.keypedia.com/companies/agios-pharmaceuticals-inc/56e211c0-dde4-4267-a2fa-29bed2c57c05)
- [Sait Ashina, M.D.](https://www.keypedia.com/companies/sait-ashina-md/c6fa4542-ae8c-4438-948f-8b3667ab5408)
- [Scholar Rock, Inc.](https://www.keypedia.com/companies/scholar-rock-inc/99595ac1-bfcf-49a3-9b13-c156e96fd102)
- [Genzyme Corporation](https://www.keypedia.com/companies/genzyme-corporation/b661247e-b581-458a-a1fc-79f4ccb29738)
- [Marcia R. Cruz-Correa, M.D., PhD](https://www.keypedia.com/companies/marcia-r-cruz-correa-md-phd/7bf43950-c1ef-4886-8c50-95e75e370880)

## Related Officers

- [Andrew S.T. Haffer](https://www.keypedia.com/people/andrew-st-haffer/bd5a9d2c-a0b2-40a2-a730-5f2f0e3f44f7)
- [Lauren DiPetrillo, PhD](https://www.keypedia.com/people/lauren-dipetrillo-phd/1b0bb714-9819-49ad-9c7a-266d9bea515b)